Reporting of Health Equity Considerations in Vaccine Trials for COVID-19: A Methodological Review
An emerging body of randomized controlled trials (RCTs) on COVID-19 vaccines has served as the evidence base for public health decision-making. While it is recommended that RCTs report results by health equity stratifiers to reduce bias in healthcare and gaps in research, it is unknown whether this was done in COVID-19 vaccine trials.
Source: Journal of Clinical Epidemiology - Category: Epidemiology Authors: Roger Kou, Sarah Lopes Sadafi, Rachael Principato, Laura N. Anderson, Romina Brignardello-Petersen, Lawrence Mbuagbaw Tags: Methods for Living Guidelines: Early Guidance based on practical experience Source Type: research
More News: Covid Vaccine | COVID-19 | Epidemiology | International Medicine & Public Health | Legislation | Vaccines